155 related articles for article (PubMed ID: 35095793)
1. Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against
Lou H; Li X; Sheng X; Fang S; Wan S; Sun A; Chen H
Front Microbiol; 2021; 12():773697. PubMed ID: 35095793
[No Abstract] [Full Text] [Related]
2. Evaluations of Alkyl hydroperoxide reductase B cell antigen epitope as a potential epitope vaccine against
Lou H; Li X; Guo F; Ding M; Hu Y; Chen H; Yan J
Saudi J Biol Sci; 2019 Sep; 26(6):1117-1122. PubMed ID: 31516338
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Prediction of Potential Vaccine Candidates for Campylobacter jejuni Using Reverse Vaccinology.
Jain R; Singh S; Verma SK; Jain A
Interdiscip Sci; 2019 Sep; 11(3):337-347. PubMed ID: 29128919
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of an immunogenic outer membrane protein of Campylobacter jejuni.
Burnens A; Stucki U; Nicolet J; Frey J
J Clin Microbiol; 1995 Nov; 33(11):2826-32. PubMed ID: 8576327
[TBL] [Abstract][Full Text] [Related]
5. Designing an efficient multi-epitope vaccine against Campylobacter jejuni using immunoinformatics and reverse vaccinology approach.
Gupta N; Kumar A
Microb Pathog; 2020 Oct; 147():104398. PubMed ID: 32771659
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model.
Albert MJ; Mustafa AS; Islam A; Haridas S
mBio; 2013 May; 4(3):e00246-13. PubMed ID: 23653448
[TBL] [Abstract][Full Text] [Related]
7. Identification and evaluation of protection effect of B-cell immunodominant epitopes of campylobacter jejuni PEB1.
Liu L; Feng J; Li Y; Liu Y; Wang Y; Hu Z; Xiong J; Zuo Q; Zhang R
Microb Pathog; 2021 Mar; 152():104650. PubMed ID: 33232766
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression, and antigenicity of 14 proteins from Campylobacter jejuni.
Zhang M; Meng F; Cao F; Qiao B; Liu G; Liu H; Zhou Y; Dong H; Gu Y; Xiao D; Zhang Y; Zhang J
Foodborne Pathog Dis; 2012 Aug; 9(8):706-12. PubMed ID: 22779748
[TBL] [Abstract][Full Text] [Related]
9. In silico analysis of epitope-based CadF vaccine design against Campylobacter jejuni.
Moballegh Naseri M; Shams S; Moballegh Naseri M; Bakhshi B
BMC Res Notes; 2020 Nov; 13(1):518. PubMed ID: 33168057
[TBL] [Abstract][Full Text] [Related]
10. Production of a monoclonal antibody specific for the major outer membrane protein of Campylobacter jejuni and characterization of the epitope.
Qian H; Pang E; Du Q; Chang J; Dong J; Toh SL; Ng FK; Tan AL; Kwang J
Appl Environ Microbiol; 2008 Feb; 74(3):833-9. PubMed ID: 18065632
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice.
Foroutan M; Ghaffarifar F; Sharifi Z; Dalimi A
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101413. PubMed ID: 31954995
[TBL] [Abstract][Full Text] [Related]
12. In silico proposition to predict cluster of B- and T-cell epitopes for the usefulness of vaccine design from invasive, virulent and membrane associated proteins of C. jejuni.
Yasmin T; Akter S; Debnath M; Ebihara A; Nakagawa T; Nabi AH
In Silico Pharmacol; 2016 Dec; 4(1):5. PubMed ID: 27376537
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Immunogenicity and Protective Efficacy of a
Ramakrishnan A; Schumack NM; Gariepy CL; Eggleston H; Nunez G; Espinoza N; Nieto M; Castillo R; Rojas J; McCoy AJ; Beck Z; Matyas GR; Alving CR; Guerry P; Poly F; Laird RM
mSphere; 2019 May; 4(3):. PubMed ID: 31043512
[No Abstract] [Full Text] [Related]
14. Expression of recombinant Omp18 and MOMP of
Borovikov S; Tursunov K; Syzdykova A; Begenova A; Zhakhina A
Vet World; 2023 Jan; 16(1):222-228. PubMed ID: 36855354
[TBL] [Abstract][Full Text] [Related]
15. Is the Campylobacter jejuni secretory protein Cj0069 a suitable antigen for serodiagnostics?
Corso J; Lugert R; Groß U; Zautner AE
Eur J Microbiol Immunol (Bp); 2011 Mar; 1(1):86-94. PubMed ID: 24466437
[TBL] [Abstract][Full Text] [Related]
16. Construction, expression, purification and antigenicity of recombinant Campylobacter jejuni flagellar proteins.
Yeh HY; Hiett KL; Line JE; Oakley BB; Seal BS
Microbiol Res; 2013 May; 168(4):192-8. PubMed ID: 23312848
[TBL] [Abstract][Full Text] [Related]
17. Identification of combined T-cell and B-cell reactive
Wang L; Gao J; Lan X; Zhao H; Shang X; Tian F; Wen H; Ding J; Luo L; Ma X
Ann Transl Med; 2019 Nov; 7(22):652. PubMed ID: 31930053
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbe-Derived Outer Membrane Vesicles: A Potential Platform to Control Cecal Load of
Singh A; Khan A; Ghosh T; Mondal S; Mallick AI
ACS Infect Dis; 2021 May; 7(5):1186-1199. PubMed ID: 33724795
[TBL] [Abstract][Full Text] [Related]
19. Arthritis, Guillain-Barré Syndrome, and Other Sequelae of Campylobacter jejuni Enteritis
Smith JL
J Food Prot; 1995 Oct; 58(10):1153-1170. PubMed ID: 31137373
[TBL] [Abstract][Full Text] [Related]
20. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
